BRWRX
Price
$27.21
Change
-$0.59 (-2.12%)
Updated
Nov 13 closing price
Net Assets
520.55M
RGEBX
Price
$83.30
Change
-$1.87 (-2.20%)
Updated
Nov 13 closing price
Net Assets
340.4B
Interact to see
Advertisement

BRWRX vs RGEBX

Header iconBRWRX vs RGEBX Comparison
Open Charts BRWRX vs RGEBXBanner chart's image
MFS Blended Research Growth Eq R1
Price$27.21
Change-$0.59 (-2.12%)
VolumeN/A
Net Assets520.55M
American Funds Growth Fund of Amer R2E
Price$83.30
Change-$1.87 (-2.20%)
VolumeN/A
Net Assets340.4B
BRWRX vs RGEBX Comparison Chart in %
View a ticker or compare two or three
VS
BRWRX vs. RGEBX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRWRX is a Hold and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 340B vs. BRWRX (521M). BRWRX (0.00) and RGEBX (0.00) have matching dividends . BRWRX was incepted earlier than RGEBX: BRWRX (10 years) vs RGEBX (11 years). BRWRX (1.43) is less costly to investors than RGEBX (1.09). BRWRX is a more actively managed with annual turnover of: 46.00 vs. RGEBX (25.00). BRWRX has a lower initial minimum investment than RGEBX: BRWRX (0) vs RGEBX (250). BRWRX annual gain was more profitable for investors over the last year : 11.69 vs. RGEBX (8.10). BRWRX return over 5 years is better than : 52.66 vs. RGEBX (36.65).
BRWRXRGEBXBRWRX / RGEBX
Total Expense Ratio1.391.09128%
Annual Report Gross Expense Ratio1.431.09131%
Fund Existence10 years11 years-
Gain YTD17.25019.21990%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets521M340B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year11.698.10144%
Returns for 3 years92.2562.39148%
Returns for 5 years52.6636.65144%
Returns for 10 years178.3893.78190%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRUG60.150.91
+1.54%
Bright Minds Biosciences
SRPT18.000.02
+0.11%
Sarepta Therapeutics
WSBCP24.98N/A
N/A
WesBanco
XP19.21-0.59
-2.98%
XP
HKIT2.37-0.39
-14.13%
Hitek Global